Clinical trials
Phase 1 Nasopharyngeal Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2012 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor College of Medicine | 4 |
| Xencor, Inc. | 3 |
| Incyte Corporation | 2 |
| Novartis Pharmaceuticals | 2 |
| Ascentage Pharma Group Inc. | 1 |
| BeiGene | 1 |
| Dana-Farber Cancer Institute | 1 |
| Emory University | 1 |
| Inhibrx Biosciences, Inc | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nasopharyngeal Carcinoma | 22 |
| Squamous Cell Carcinoma of Head and Neck | 8 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Carcinoma, Renal Cell | 6 |
| Carcinoma, Transitional Cell | 6 |
| Melanoma | 6 |
| Stomach Neoplasms | 6 |
| Carcinoma, Hepatocellular | 5 |
| Head and Neck Neoplasms | 5 |
| Mesothelioma | 5 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.